AstraZeneca’s Gut Instinct: CEO-Designate Is Nexium Brand Builder Brennan
Executive Summary
AstraZeneca is elevating an executive integral to the commercial success of the company's proton pump inhibitor franchise with the appointment of U.S. head David Brennan as CEO